Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a screening device for autism in young children

Tests whether the SenseToKnow device can detect autism in children aged 16 to 36 months.

Plain-language title generated from the registry record
Registry title: SenseToKnow Autism Screening Device Validation Study

Key facts

Where
Durham, United StatesSee the site

Where in United States

  • Duke UniversityDurham, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Duke University
Trial code
NCT05874466
Record updated
6 March 2026
Original description
This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow device for the detection of autism spectrum disorder in children 16-36 months of age.Read full original descriptionShow less

SenseToKnow STAR Study: A Study of Technologies for Assessing Children's Development

This is a pivotal, prospective, double-blind, study to evaluate the sensitivity and specificity of the SenseToKnow device for the detection of autism spectrum disorder in children 16-36 months of age.

Inclusion: Duke Health pediatric patient at enrollment; 16-<37 months of age at enrollment; Parent/legal guardian speaks English or Spanish; Parent/legal guardian understands and voluntarily provides informed consent.

Exclusion: Receiving therapies that affect vision; Severe motor impairment that precludes study measure completion; Known genetic disorders; Severe hearing or visual impairment as determined on physical examination according to parent report; Acute illnesses likely to prevent successful or valid data collection; Uncontrolled epilepsy or seizure disorder; History or presence of a clinically significant medical disease, or a mental state that could confound the study or be detrimental to the subject as determined by the investigator; Acute exacerbations of chronic illnesses likely to prevent successful or valid data collection; Parent/legal guardian and/or investigator believes that the child will be unable/unwilling to sit in the parent's lap to watch the app videos; Parent/legal guardian indicates that they or their child is unwilling or unable to complete the app administration, surveys, or diagnostic assessment; Participants who are otherwise judged as unable to comply with the protocol by the investigator; Any other factor that the investigator feels would make the study measures invalid.

ClinicalTrials.gov NCT05874466